| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 72,9 k € | -47.3% | 138,5 k € | -38.2% | 224,1 k € | -26.7% | 305,5 k € | -0.2% | 306,3 k € | +13.6% | 269,5 k € | -11.3% | 303,9 k € | -23.4% | 397,0 k € | -8.5% | 434,0 k € | +20.2% | 361,1 k € | -5.2% | 381,0 k € | +2.2% | 372,7 k € | +2.8% | 362,5 k € | +2.4% | 353,9 k € | +4.8% | 337,8 k € | -1.0% | 341,2 k € | +22.9% | 277,7 k € | -33.5% | 417,3 k € | |
| EBITDA | 71,4 k € | -47.9% | 137,0 k € | -38.1% | 221,2 k € | -18.1% | 270,2 k € | -1.6% | 274,5 k € | +13.6% | 241,7 k € | -11.3% | 272,3 k € | -24.2% | 359,5 k € | -11.0% | 404,0 k € | +21.9% | 331,3 k € | -7.3% | 357,6 k € | +2.1% | 350,3 k € | +3.1% | 339,9 k € | +2.8% | 330,7 k € | +11.6% | 296,2 k € | -7.2% | 319,1 k € | +26.6% | 252,0 k € | -35.1% | 388,2 k € | |
| Operating profit | 66,3 k € | -47.8% | 126,9 k € | -37.8% | 203,9 k € | -19.1% | 252,0 k € | +0.3% | 251,3 k € | +21.3% | 207,1 k € | -12.9% | 237,8 k € | -25.9% | 321,1 k € | -10.9% | 360,3 k € | +22.5% | 294,1 k € | -13.9% | 341,5 k € | +0.6% | 339,5 k € | +8.9% | 311,8 k € | +5.2% | 296,3 k € | +14.4% | 258,9 k € | -4.1% | 270,0 k € | +33.8% | 201,7 k € | -39.6% | 334,2 k € | |
| Profit/loss | 87,6 k € | -25.0% | 116,8 k € | -32.8% | 173,9 k € | +21.6% | 143,0 k € | -22.2% | 183,9 k € | +14.0% | 161,3 k € | +4.1% | 155,0 k € | -37.0% | 246,1 k € | +13.3% | 217,2 k € | +20.4% | 180,4 k € | -10.0% | 200,4 k € | -8.4% | 218,9 k € | +4.6% | 209,3 k € | +5.3% | 198,7 k € | -2.4% | 203,7 k € | -5.9% | 216,6 k € | +30.3% | 166,2 k € | -43.7% | 295,3 k € | |
| Equity | 1,2 M € | -5.0% | 1,3 M € | -6.2% | 1,3 M € | -12.2% | 1,5 M € | +10.3% | 1,4 M € | -7.1% | 1,5 M € | -11.2% | 1,7 M € | +10.2% | 1,5 M € | +19.3% | 1,3 M € | +20.5% | 1,1 M € | +20.5% | 879,2 k € | +29.5% | 678,7 k € | +1881.7% | 34,3 k € | -94.4% | 609,0 k € | +0.6% | 605,2 k € | +0.6% | 601,5 k € | +3.7% | 580,0 k € | +0.2% | 578,7 k € | |
| Total assets | 1,7 M € | +7.6% | 1,6 M € | -9.0% | 1,7 M € | +5.7% | 1,6 M € | -5.7% | 1,7 M € | +8.1% | 1,6 M € | -6.4% | 1,7 M € | -7.7% | 1,9 M € | +33.7% | 1,4 M € | +10.8% | 1,3 M € | +22.5% | 1,0 M € | +13.9% | 900,9 k € | +1.9% | 884,1 k € | -3.9% | 920,4 k € | +5.7% | 870,8 k € | +1.8% | 855,3 k € | -3.4% | 885,4 k € | -11.1% | 996,5 k € | |
| Cash | 42,2 k € | -88.7% | 374,1 k € | -32.8% | 557,0 k € | -13.1% | 640,9 k € | +2.3% | 626,2 k € | -6.9% | 672,6 k € | +22.4% | 549,6 k € | +16.3% | 472,5 k € | +116.9% | 217,8 k € | -60.5% | 551,2 k € | +121.2% | 249,2 k € | +78.8% | 139,3 k € | +7.6% | 129,5 k € | +33.1% | 97,3 k € | +132.6% | 41,8 k € | +121.5% | 18,9 k € | -80.1% | 94,7 k € | -59.6% | 234,4 k € | |
| Debts | 486,7 k € | +59.2% | 305,6 k € | -21.2% | 388,0 k € | +257.8% | 108,4 k € | -68.9% | 348,7 k € | +202.7% | 115,2 k € | +179.5% | 41,2 k € | -87.9% | 340,0 k € | +191.1% | 116,8 k € | -41.1% | 198,3 k € | +34.5% | 147,4 k € | -33.6% | 222,1 k € | -73.9% | 849,8 k € | +172.9% | 311,4 k € | +17.4% | 265,3 k € | +4.6% | 253,7 k € | -16.9% | 305,4 k € | -25.9% | 412,3 k € | |
| Staff | — | — | — | — | — | — | — | — | — | — | 0,5 | 0,5 | 0,5 | 0,5 | 0,5 | 0,5 | 0,5 | 0,6 | ||||||||||||||||||
Private limited company · Eupen · incorporated on 01/06/2001
Private limited company profitable and well capitalised. Cash position declining (-88.7%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
CABINET MEDICAL INGELS-DEMEUNYNCK is a Private limited company incorporated in 2001. Its main activity is: Specialist medical practice activities. Its registered office is in Eupen.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette